HF
HELP

HRT Financial’s Helus Pharma Inc. Common Stock HELP Stock Holding History

HRT Financial’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823K Sell
124,658
-62,394
-33% -$312K ﹤0.01% 2283
2026
Q1 		$897K Buy
+187,052
New +$1.21M ﹤0.01% 2130
2024
Q2 		– Sell
-781
Closed -$12K – 2373
2024
Q1 		$12K Buy
781
+148
+23% +$2.14K ﹤0.01% 2050
2023
Q4 		$9K Buy
+633
New +$11.8K ﹤0.01% 2088
2023
Q3 		– Sell
-386
Closed -$5K – 2521
2023
Q2 		$5K Buy
+386
New +$4.64K ﹤0.01% 2235
2023
Q1 		– Sell
-652
Closed -$7K – 2605
2022
Q4 		$7K Buy
+652
New +$10.8K ﹤0.01% 2250

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

HRT Financial's HELP Position: Q2 2026 in Review

HRT Financial reduced its Helus Pharma Inc. Common Stock (HELP) stake by 33% in Q2 2026, selling an estimated $312K and leaving 124,658 shares worth $823K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

HRT Financial first reported a position in HELP in Q4 2022 and has held it in 6 quarters since. The position peaked at $897K in Q1 2026. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • HRT Financial held 124,658 shares of Helus Pharma Inc. Common Stock worth $823K as of Q2 2026.
  • HRT Financial sold 62,394 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $312K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2283 holding.
  • HRT Financial first reported a position in Helus Pharma Inc. Common Stock in Q4 2022 and has held it in 6 quarters since.
  • HRT Financial's Helus Pharma Inc. Common Stock position peaked at $897K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.